MedPath

Effect of Viola odorata syrup on aleviating the manifestations of COVID-19 (Corona) infection: A double-blind placebo controlled trial

Phase 3
Recruiting
Conditions
COVID-19.
Coronavirus infection, unspecified
B34.2
Registration Number
IRCT20190409043215N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients referred to Al-Zahra Hospital (Isfahan) who diagnosed COVID-19 based on clinical symptoms and blood oxygen saturation along with CT scan of the lung with the approval of a radiologist and / or positive PCR for them.
Blood oxygen saturation greater than or equal to 90%.
The age range of patients is 15 to 75 years
Both sexes
Satisfaction to participate in the study

Exclusion Criteria

Diabetic patients
Patients with allergies to herbal products
Severe forms of covid-19 disease (respiratory rate> 24 or percnt of blood saturated oxygenation <90%)
Patients with diarrhea

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of shortness of breath. Timepoint: Once a day for 6 days. Method of measurement: Questionary.;Intensity of cough. Timepoint: Once a day for 6 days. Method of measurement: Questionnaire.;Blood oxygen. Timepoint: Once a day for 6 days. Method of measurement: Pulse oximeter.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath